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Objective: To undertake the first detailed genomic analysis of methicillin-resistant
Staphylococcus aureus (MRSA) isolated in Sri Lanka.
Methods: A prospective observational study was performed on 94 MRSA isolates
collected over a 4 months period from the Anuradhapura Teaching Hospital, Sri Lanka.
Screening for mecA, mecC, and the Panton-Valentine leucocidin (PVL)-associated
lukS-PV/lukF-PV genes and molecular characterization by spa typing was undertaken.
Whole genome sequencing (WGS) and phylogenetic analysis was performed on selected
multilocus sequence type (MLST) clonal complex 5 (CC5) isolates from Sri Lanka,
England, Australia, and Argentina.
Results: All 94 MRSA harbored the mecA gene. Nineteen spa types belonging to nine
MLST clonal complexes were identified. Where origin of the sample was recorded, most
isolates were from skin and soft tissue infections (70/91; 76.9%), with fewer causing
bacteremia (16/91; 17.6%), empyema (3/91; 3.3%) and osteomyelitis (2/91; 2.2%). Sixty
two (65.9%) isolates were PVL positive with the majority (56 isolates; 90.3%) belonging
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to a dominant CC5 lineage. This lineage, PVL-positive ST5-MRSA-IVc, was associated
with both community and hospital-onset infections. Based on WGS, representative
PVL-positive ST5-MRSA-IVc isolates from Sri Lanka, England and Australia formed a
single phylogenetic clade, suggesting wide geographical circulation.
Conclusions: We present the most detailed genomic analysis of MRSA isolated in Sri
Lanka to date. The analysis identified a PVL-positive ST5-MRSA-IVc that is prevalent
among MRSA causing clinical infections in Sri Lanka. Furthermore, this clone was also
found among isolates from the United Kingdom and Australia.
Keywords: methicillin resistant Staphylococcus aureus, Panton-Valentine leucocidin, Sri Lanka, CC5, whole
genome sequencing
INTRODUCTION
Worldwide, Staphylococcus aureus is the primary causative agent
of community-acquired skin and soft tissue infections (SSTI) and
is an important cause of hospital-associated invasive infections
including bacteremia, pneumonia and endocarditis (Bell et al.,
2002; David and Daum, 2010). Panton-Valentine leucocidin
(PVL)-positive Methicillin Resistant S. aureus (MRSA) is a
well-documented cause of community-associated SSTI and less
commonly, life-threatening infections in immunocompetent
populations. Its prevalence is thought to be increasing worldwide
and multi drug resistant PVL-MRSA is emerging as a threat,
particularly in the Indian subcontinent (Song et al., 2011;
Shallcross et al., 2013). In many developed countries, surveillance
of MRSA invasive disease, characterization of high risk MRSA
clones and the investigation of suspected MRSA outbreaks are
achieved through public health tracking and molecular analysis.
By comparison, limited data exist on MRSA infections in low
and middle-income countries. A recent report has suggested Sri
Lankan hospitals have the highest prevalence of MRSA for all
Asian hospitals that were included in the study (Song et al.,
2011). However, information on the molecular epidemiology
and spectrum of clinical disease is lacking (Corea et al., 2003;
Mahalingam et al., 2014; Jayaweera and Kumbukgolla, 2017;
Jayaweera et al., 2017). Consequently in our study, we report on
the genomic analysis of MRSA isolated from patients admitted to
a major teaching hospital in Sri Lanka.
METHODS
Aprospective, observational study of sequentialMRSA infections
in hospitalized patients was conducted at the Anuradhapura
Teaching Hospital from 30th June to 31st October 2014. This
hospital serves ∼1.6 million people living in the rural North
Central province of Sri Lanka. All MRSA isolated from any
site with a clinical infection during the 4-months period were
included in the study. S. aureus species identification from
clinical samples was confirmed by colony morphology, catalase
and tube coagulase tests. Screening for methicillin resistance was
undertaken via disc diffusion testing using oxacillin, incubation
on Mueller-Hinton agar at 33–35◦C for 24 h, and interpreted
according to CLSI 2005 guidelines. Ethical approval was obtained
from the Ethics Review Committee, Rajarata University of
Sri Lanka. Infections were defined as community-acquired
(CA) if the sample was collected <48 h from admission and
hospital-acquired (HA) if collected later, based on previous
studies distinguishing whether MRSA infection were likely to be
acquired in community or hospital settings (Cardoso et al., 2014).
Isolates were referred to the Staphylococcal Reference Service,
National Infection Service, Public Health England (PHE),
Colindale, London for further analysis. Initial identification was
performed using the MALDI-TOF (MALDI Biotyper R©, Bruker
Daltonik GmbH, Germany), followed by real-time polymerase
chain reaction (PCR) for mecA and lukS-PV/lukF-PV genes, to
determine the isolate’s methicillin resistance, Panton-Valentine
leucocidin (PVL) status, and spa typing (Frénay et al., 1996;
Pichon et al., 2012).
Whole genome sequencing (WGS) on selected isolates
was undertaken as previously described (Garvey et al., 2016;
Lahuerta-Marin et al., 2016). Genomic DNA was extracted
using the Qiagen DNA mini kit (Qiagen) and QIAsymphony
instrument (Qiagen). DNA libraries were prepared with the
Nextera XT kit (Illumina, Cambridge, UK) and sequenced on the
Illumina HiSeq 2500 instrument (Illumina), generating 100 base
paired end fragments. Sequence types (ST) were derived from
WGS sequences using MOST (Tewolde et al., 2016). By mapping
WGS reads against reference sequences using bowtie (Langmead
et al., 2009), a broad range of loci were screened for virulence
factors and the immune evasion cluster (IEC), in addition to
genes and chromosomal mutations associated with antimicrobial
resistance (Lahuerta-Marin et al., 2016; Sharma et al., 2016).
Staphylococcal Cassette Chromosome mec (SCCmec) types were
deduced based on the detection of the mec complex and
ccr genes by BLAST on assembled genomes generated using
SPAdes (Bankevich et al., 2012). The phylogenetic relationship
between isolates was determined at the core genome level by
Single Nucleotide Polymorphism (SNP) analysis using an in
house pipeline (phenix; https://github.com/phe-bioinformatics/
PHEnix). Sequence reads were mapped to an ST8-MRSA
reference sequence (NC_007795) and SNPs were called and
filtered using the GenomeAnalysis Toolkit v2.0 (VanDer Auwera
et al., 2013). The resulting alignment was used for maximum
likelihood analyses using RAxML v.0 8.2.8 (Stamatakis, 2014)
under the GTRCATmodel with 100 bootstraps. The best tree was
drawn using the ITOL application (Letunic and Bork, 2016). The
sequence data supporting the results of this article are available
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in the European Nucleotide Archive, under project accession
number PRJEB27049.
RESULTS
The 94 isolates submitted for further testing were confirmed as
S. aureus by MALDI-TOF and were mecA positive (Table 1).
Where clinical data were available (n = 91), the majority
of MRSA isolates (n = 70, 76.9%) were from skin and soft
tissue infections (SSTIs), with the remainder from invasive
infections, including 16 (17.6%) MRSA bacteremias (Table 1).
Five deaths occurred, all in patients with bacteremia. Based
on the 19 spa types identified, the isolates could be grouped
into nine MLST clonal complexes (CC) including: CC5 (n
= 59 isolates), CC30 (n = 18), CC1 (n = 8), CC59 (n =
4), and single isolates belonging to CC6, CC8, CC45, CC97,
and CC101. The dominant CC5 MRSA lineage (62.7% of
isolates) was comprised of six related spa types: t002 (n =
51), t010 (n = 4), and single isolates of t045, t1062, t5490,
and t7342. Sixty two (65.9%) isolates were PVL positive, the
majority (56 isolates; 90.3%) belonging to the CC5 lineage.
Where clinical details were available, the CC5 PVL-positive
lineage was associated mainly with HA- and CA-SSTIs (42/50;
84.0%), but was also responsible for more invasive infections
(Table 1), such as bacteremia (5/50; 10.0%), empyema (2/50;
4.0%) and osteomyelitis (1/50; 2.0%). Two deaths occurred,
both in patients with bacteremia. All HA-SSTIs were surgical
wound infections.
To investigate whether the CC5 PVL-positive lineage was
genotypically diverse, or a single circulating clone, WGS was
performed on 34 isolates selected to include both invasive
(four bacteremia and one osteomyelitis) and SSTI (n = 29)
infections, samples from both children and adults, and a diverse
range of spa types (28 t002 and six samples from other
spa types). As CC5 PVL-positive MRSA have been identified
sporadically in England, we sought to assess the relatedness
of the Sri Lankan isolates to lineage-matched isolates held
in the PHE archives, which represent samples submitted to
a national reference laboratory. These included isolates from
patients with known travel links to Sri Lanka (10 CC5 PVL-
positive MRSA isolates collected between 2005 and 2014 but
not known to be linked to each other in time or place) and
patients with no known travel links to Sri Lanka (79 isolates:
12 CC5 PVL-positive MRSA isolates collected between 2005 and
2015, 33 CC5 PVL-negative MRSA isolates collected between
2009 and 2016, 4 CC5 PVL-positive methicillin-sensitive S.
aureus (MSSA) isolates collected between 2011 and 2016, and
30 CC5 PVL-negative MSSA isolates collected between 2011
and 2016). Previously sequenced CC5 PVL-positive MRSA
from collaborators in Australia (n = 14, collected in 2015)
TABLE 1 | Genotypic, demographic and clinical characteristics of MRSA isolates from Sri Lanka.
spa types (No.) PVL No. subjected to WGS Age distribution (Years)a Clinical presentations* Hospital or community acquired (No.)
<1 1–15 16–60 >60 NK SSTI BAC EMP OM NK
CC1 t657 (n = 3) + ND 1 2 2 1 CA (2), NK (1)
t127 (n = 5) +
(n = 1)
ND 2 2 1 5 CA (2), HA (3)
CC5 t002 (n = 51) +
(n = 50)
28 8 15 22 5 1 42 5 2 1 1 CA (25), HA (9), NK (17)
t010 (n = 4) +
(n = 3)
3 3 1 3 1 CA (4)
t045 (n = 1) + 1 1 1 CA(1)
t1062 (n = 1) + 1 1 1 CA (1)
t5490 (n = 1) + 1 1 1 HA (1)
t7342 (n = 1) – ND 1 1 CA (1)
CC6 t304 (n = 1) – ND 1 1 CA (1)
CC8 t008 (n = 1) – ND 1 1 CA (1)
CC30 t021 (n = 2) + ND 1 1 1 1 NK (1), CA (1)
t425 (n = 13) – ND 2 10 1 6 6 1 CA (5), HA (8)
t15007 (n = 1) – ND 1 1 HA (1)
t4410 (n = 2) – ND 1 1 2 HA (1), CA (1)
CC45 t465 (n = 1) – ND 1 1 HA (1)
CC59 t437 (n = 1) – ND 1 1 HA (1)
t7028 (n = 3) – ND 2 1 1 1 1 HA (2), NK (1)
CC97 t15010 (n = 1) – ND 1 1 HA (1)
CC101 t1212 (n = 1) – ND 1 1 NK (1)
All isolates were mecA positive by PCR. SSTI, skin and soft tissue infection; *Hospital-acquired cases of SSTI were surgical wound infections; BAC, bacteremia; EMP, empyema; OM,
osteomyelitis; CA, community-acquired; HA, hospital-acquired; ND, not done; NK, not known.
aGender distribution of cases: 48 male, 40 female, 6 no data available.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 April 2019 | Volume 9 | Article 123
McTavish et al. PVL MRSA Dominant in Sri Lanka
and Argentina (n = 3; collected in 2003) were also included
as comparators.
Phylogenetic analysis of CC5 strain WGS showed great
variability (Figure 1A), with isolates from various countries
dispersed throughout the tree. A strong geographic signal
however was apparent amongst the isolates from Sri Lanka, with
all but three CC5-PVL-positive MRSA isolates clustering into a
single clade, herein dubbed the “Sri Lankan clade” (Figure 1B).
Isolates from the United Kingdom (13) and Australia (1)
were also found in the Sri Lankan clade, including three
from patients with no known links to Sri Lanka. Within the
clade, the isolates were identified as multilocus sequence type
(ST) 5 and the MRSA isolates harbored the SCCmec IVc
staphylococcal cassette chromosome mec subtype. All but one
isolate encoded enterotoxin genes (sed, sej, and ser) usually
found on plasmids (Fisher et al., 2018). Greater variability
was apparent for other traits including the sep enterotoxin
gene. Genes encoding resistance to erythromycin [erm(C)] or
tetracycline [tet(K)] were variably detected highlighting the
dynamic loss/acquisition of mobile genetic elements within
the clone. Similarly, a chromosomal mutation associated with
quinolone resistance (grlA 80:S-F) was noted sporadically. A
single isolate from a UK patient with links to Sri Lanka was
identified as being genotypically multi-drug resistant, encoding
blaZ, mecA, erm(C), tet(K), aphA3, and sat4 genes. Bayesian
phylogenetic reconstruction using BEAST (data not shown)
failed to provide significant temporal signal for predicting
evolutionary rate and time to common ancestor.
FIGURE 1 | Alignment of international MLST CC5 Staphylococcus aureus genomes. (A) Unrooted phylogenetic tree indicating relationships between international
CC5 S. aureus including their PVL (⋆) and mecA () status based on SNP analysis of whole genome sequences. Clinical information relating to each isolate is also
shown (red: invasive, blue: skin and soft tissue infection, green: screening/carriage sample, gray: unknown). Phylogeny was inferred by maximum likelihood analysis
using RAxML GTRCAT model with 100 bootstraps from aligned polymorphic sites allowing 20% of Ns and gaps. Polymorphic sites were called using GATK2 and
filtered (AD ratio = 0.9; min depth = 10; MQ score >30; QUAL score >40) using genome NC_002745 as mapping reference. The tree was drawn using the ITOL
application. Country of origin denoted as follows in sample identifiers at tips: blue: England; red: Sri Lanka; green: Australia; yellow: Argentina. Scale is in substitutions
per site and indicates ≈ 130 SNPs. (B) Indicates UK patients with known links to Sri Lanka. SCCmec types: IV-a; IV-c; VI; NT. In gene profile section, 
indicates presence of gene. All sequenced mecA-positive isolates also contained the ß-lactamase encoding gene blaZ. Scale is in substitutions per site and
represents ≈ 13 SNPs.
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DISCUSSION
Particular lineages of MRSA are frequently associated with
various geographical origins e.g., ST8/USA300 (North America);
ST93 (Australia); ST80 (North Africa); ST30 (South-West Pacific)
(David and Daum, 2010; Chua et al., 2011). Prior to the current
study, CC5 PVL-positive MRSA was reported in many countries
world-wide (Monecke et al., 2011); however, their origin(s) are
unclear. A recent phylogenomic study of CC5-MRSA isolates
from the Western Hemisphere showed high diversity, even
among strains that shared the same SCCmec type circulating in
the same country (Challagundla et al., 2018). A study of S. aureus
bacteremia isolates from nine Latin American countries reported
that the majority of MRSA belonged to CC5 (Arias et al., 2017).
Very few whole genome sequences from CC5-MRSA isolates
from Asian countries are currently available.
Herein, in most instances, phylogenetic analysis of CC5
PVL-positive MRSA from four continents showed clustering
according to their geographic location, suggesting they have
arisen independently in different parts of world following the
acquisition of PVL phage and/or different SCCmec elements.
Our data provide evidence of a successful ST5-PVL-positive
MRSA-IVc clone in Sri Lanka which also appears to be present
in distant geographical regions. Thirteen isolates from England
were interspersed within the Sri Lankan clade; ten with known
links to Sri Lanka. One isolate from Australia also clustered
within the Sri Lankan clade, however a link to Sri Lanka could
not be determined.
Whilst in our study all Sri Lankan isolates were collected
systematically without undue bias, it is important to acknowledge
that the number of isolates is small and that they were collected
from a single center over a relatively short timeframe. However,
the UK CC5 PVL-positive MRSA isolates in the Sri Lankan clade,
including those with known links to Sri Lanka, were collected
over the course of a decade prior to our study. This suggests
that wider circulation of this PVL-positive ST5-MRSA-IVc clone
is likely in Sri Lanka and that our newly collected samples
do not simply represent a clonal outbreak in Anuradhapura
Teaching Hospital. With our current dataset, it is not possible
to definitively conclude whether this clone originated from Sri
Lanka and spread to the UK and Australia, or whether the
origin is from another country. A larger study of isolates from
other parts of Sri Lanka and globally would be required to help
elucidate the origins and dissemination of PVL-positive MRSA
belonging to the CC5 lineage. Travel- and migration-related
acquisition and importation of MRSA strains to Europe is well-
described, including a high proportion of PVL-positive isolates
causing SSTI (Nurjadi et al., 2015, 2018). The ST5-PVL-positive
MRSA-IVc clone identified was also responsible for both CA-
and HA-infections, emphasizing the increasingly blurred lines
between community and hospital-associated infections reported
(Skov and Jensen, 2009). We also had limited CC5 PVL-negative
MRSA isolates from Sri Lanka and did not perform WGS on
these. Since PVL are carried on bacteriophages (Boakes et al.,
2011), it is possible that we have missed isolates within the ST5-
MRSA-IVc clade that have lost PVL. Again, a larger study is
required to explore this possibility. Furthermore, such a study
would allow comprehensive characterization of genetic factors
important in the uptake of PVL in various CC5 clades.
In conclusion, we have presented the most detailed genomic
analysis of MRSA isolated in Sri Lanka to date and have
demonstrated, at least in the hospital and catchment area studied,
that clinical MRSA infections in Sri Lanka are dominated by
a PVL-positive ST5-MRSA-IVc clone. We have also shown the
clone can be found in English patients with a history of travel to
Sri Lanka. Further work is required to determine the prevalence
of carriage and infection associated with PVL-positive ST5-
MRSA-IVc in Sri Lanka, and the dynamics of transmission in and
out of hospital, and whether these findings are replicated on a
national scale.
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